This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 02:44, 18 February 2012 (Updating {{drugbox}} (changes to verified fields - added verified revid - updated 'ChEBI_Ref') per Chem/Drugbox validation (report errors or bugs)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 02:44, 18 February 2012 by CheMoBot (talk | contribs) (Updating {{drugbox}} (changes to verified fields - added verified revid - updated 'ChEBI_Ref') per Chem/Drugbox validation (report errors or bugs))(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Acrisorcin" – news · newspapers · books · scholar · JSTOR (May 2008) (Learn how and when to remove this message) |
Combination of | |
---|---|
4-Hexylresorcinol | Antiseptic |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.028.536 |
Chemical and physical data | |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Acrisorcin is a topical anti-infective typically used as a fungicide. It is a combination of the active ingredients 9-aminoacridine and 4-hexylresorcinol.
History
Acrisorcin was marketed as a cream under the trade name Akrinol, which has since been discontinued. It was developed at Indiana State University in 1961.
Indications
Acrisorcin was used to combat pityriasis versicolor.
References
This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it. |